The [4-thio]-S-ribosylhomocysteine (SRH) analogs containing substitution of a sulfur atom for the endocyclic oxygen were synthesized by coupling of the 4-thioribose substrates with a thiolate generated from the protected homocysteine. Coupling of the protected 1-deoxy-5-O-mesyl-S-oxo-4-thio-D-ribofuranose with homocysteinate salt gave the C4 epimers of [4-thio]-SRH at the sulfoxide oxidation level lacking a hydroxyl group at anomeric carbon. Treatment of these sulfoxides with BF3·Et2O/NaI affected simultaneous reduction to sulfide and global deprotection affording 1-deoxy-4-thio-SRH analog. Treatment of the protected 1-deoxy-S-oxo-4-thio-D-ribofuranose sulfoxide with DAST/SbCl3 resulted in the fluoroPummerer rearrangement to give 4-thio-β-D-ribofuranosyl fluoride. Mesylation of the latter at 5-hydroxyl position followed by coupling with homocysteinate salt and subsequent global deprotection with trifluoroacetic acid afforded [4-thio]-SRH thiohemiacetal.
Introduction
Quorum sensing (QS) is a type of bacterial cell-to-cell communication mediated through the production, release and detection of the small signaling molecules called autoinducers (AIs).
1 Such communication allows bacterial control of crucial functions in united communities for enhancement of symbiosis, virulence, antibiotic production, biofilm formation, and many other processes. 2, 3 There have been great interests in the synthesis of both small [4] [5] [6] [7] [8] and macro 9 molecules and that can modulate and/or inhibit QS pathways. S-Ribosylhomocysteinase (LuxS; EC 4.4.1.21) is a key enzyme in the biosynthetic pathway of type II autoinducer, which mediates the interspecies QS among both Gram-positive and Gram-negative bacteria. 10 The biosynthesis of AI-2 starts with depurination of Fig. 1 ). SRH is subsequently converted to L-homocysteine and 4,5-dihydroxy-2,3-pentadione (DPD) by the LuxS enzyme. DPD undergoes cyclization to 2 and complexation with borate to form a furanosyl borate diester, which acts as the AI-2 in some bacteria. 10, 12 Chemical synthesis of the unstable DPD, 13, 14 and its analogs, 6, 15 allowed to study the complexation of DPD with borate 16 and its isomerization processes. 17 LuxS is a small metalloenzyme (157 amino acids in the Bacillus subtilis enzyme) containing Fe 2+ ion. The native enzyme is unstable under aerobic conditions, but substitution of Co 2+ for Fe 2+ gives a highly stable variant with essentially wild-type catalytic activity. 18, 19 In the proposed catalytic mechanism, LuxS catalyzes consecutive aldose-ketose (1a → 1b) and ketose-ketose (1b → 1c) isomerization steps and then β-elimination of Hcy from a 3-keto intermediate (1c → 1d) to form DPD. 11, 12 Various SRH analogs have been recently designed and synthesized as a mechanistic probes and/or inhibitors of LuxS enzyme. 5, 6, 20 Among them, SRH analogs that blocked initial (such as thioether 3, Fig. 2 ) and final mechanistic steps of LuxS catalytic cycle, 21 stable analogs of the putative enediolate intermediate, 23 and substrates lacking enolizable hydroxyl group at C3 24 including mechanistically significant C3 halogenated [3-Br or F]-SRH analogs. 25 Recently, we reported [4-aza] -SRH analogs containing substitution of a nitrogen atom for the endocyclic oxygen. 22 The analog 4 that contains azahemiacetal (N,O-acetal) moiety exhibited time-dependent inhibition, consistent with LuxS-catalyzed ring opening and generation of 2-and/or 3-ketone intermediates, which presumably bind to the enzyme active site with higher affinity than the ribose natural substrate. 22 The cyclic azahemiacetals and their ancestor lactams were found to modulate Pseudomonas aeruginosa QS. 26 Here, we report synthesis of [4-thio] -SRH mimics in which the furanose ring oxygen has been replaced by a sulfur atom. The resulting thiohemiacetals (O,S-acetals) should have different stabilities relative to the O,O-acetals present in SRH and as a result different rates of metabolic alteration. Although replacement of the sugar ring oxygen by sulfur provides close mimics of natural sugars, it is noteworthy that the sulfur atom is larger and more polarizable than oxygen and the carbon-sulfur bond is longer (C-S, 0.182 nm vs. C-O, 0.143 nm), weaker and less polar than a carbon-oxygen bond (electronegativities on the Sanders scale: O, 3.65; S, 2.96; C, 2.75). 27 Such differences are responsible for significant alterations in the anomeric effect, conformational behavior, chemical reactivity, molecular recognition by proteins, biological activity, 28 and metabolic stability of thiosugars analogs in comparison with their oxygen counterparts. For example, mutarotation of such thiosugars is reported to be basebut not acid-catalyzed resulting from the lower basicity of sulfur compared to oxygen in natural sugars. 29 Also, an adjacent sulfur atom stabilizes a carbenium ion to a greater extent than an adjacent oxygen. 30 Moreover the N-4-thioriboyl linkage in thionucleosides is more stable against both chemical and enzymatic hydrolysis than the glycosylic bond in natural nucleosides. 31, 32 Thus, increased stability of the cyclic thioacetal bonds (e.g. in 21) should result in decreased rates of metabolic degradation and effect productions of the open chain aldehyde form necessary for the first LuxS-catalyzed isomerization to occur. Furthermore, the [4-thio]SRH analogs can be converted to a thio analog of DPD which could interfere QS because of different capabilities of sulfur atom to form covalent bonds to borate to generate a potential thio analogs of AI-2 signaling molecule.
S-adenosyl-L-homo-cysteine (SAH) to S-ribosyl-L-homocysteine (SRH,

Results and discussion
Synthesis of 1-deoxy-[4-thio]-S-ribosylhomocysteines
Our first target was [4-thio]-RSH analog 12a lacking the hydroxyl group at C1 (Scheme 1). Compound 12a cannot undergo ring opening which should preclude the initial step of LuxScatalyzed reactions 21 and therefore act as competitive inhibitor of LuxS. Synthesis of 12a started from 1-deoxy thiosugar precursor 5, which can be prepared from D-ribose or D-gulonolactone following Matsuda 33 or Jeong 34, 35 procedures. However, attempted activation of the 5-hydroxyl group in 5 with mesyl chloride, instead of providing the corresponding 5-O-mesyl precursor for the coupling with homocysteine, resulted in the formation of thiopyranose 9a as a mixture of two diastereoisomers (~3:1). Presumably the mesylated thiosugar underwent a rearrangement reaction into the thiopyranoses through an episulfonium ion intermediates. 36 To avoid such ring enlargement, thioether 5 was first oxidized to sulfoxide 6 with 3-chloroperbenzoic acid (m-CPBA). Interestingly, sulfoxide 6 was obtained in 94% yield as a single diastereoisomer, 37 whose stereochemistry was tentatively assigned as S at sulfur atom. The stereoselective oxidation likely is the result of the known complexation of alcohols (5-OH group) with m-CPBA which followed by cis delivery of oxygen to sulfur. 38 It also worth mentioning that oxidation of the analogous 5-O-protected 4-thiopentofuranoses with m-CPBA, which are depleting of such complexation, provided the corresponding sulfoxides as a mixture of diastereomers 33 (vide infra oxidation of 13 to 14; Scheme 2). Mesylation of 6 provided stable 5-O-mesyl sufloxide 7 as a single isomer. From different approaches available for the coupling of ribose and Hcy derivatives, 11, 21, 24, 39, 40 we found that displacement of the mesylate group from 7 with a thiolate, generated from the suitably protected L-homocystine 24 and LDA in DMF yielded 5-thioethers 10a and 10b as a separable mixture of epimers at C4 [10a (4S, D-ribo)/10b (4R, L-lyxo), 45:55] .
The structures for 10a and 10b were established based on the spectroscopic and experimental evidences as well as literature precedents. Thus, NOESY experiments of 10a showed correlation between protons H3 and H5,5′ (cis to each other) and lack of cross peaks between protons H4 and H2 (trans to each other). On the other hand, NOESY experiment of 10b showed cross peaks between protons H4 and H2 (cis to each other) and lack of space interactions between protons H3 and H5,5′ (trans to each other) confirming L-lyxose configuration. Apparently LDA base used for the condensation between thiofuranose 7 and Hcy caused epimerization at C4 position of the sugar. MacCulloch and Walker reported that treatment of the individual 4′-thionucleoside R and S sulfoxides with NaOD/D2O resulted in the epimerization at C4′ without racemization of the chiral sulfoxides. 41 We also showed that treatment of 7 with LDA in DMF without Hcy presence resulted in the formation of exomethylene Treatment of sulfoxides 10a and 10b with aqueous TFA affected removal of the N-Boc, acetonide and t-butyl ester protection groups in a single step yielding SRH analogs 11a and 11b lacking hydroxyl group at C1 and with the oxidized endocyclic sulfur atom (throughout the paper numbering of the atoms in the SRH analogs follow the nomenclature of S-ribosylhomocysteine). Treatment of the sulfoxides 10a and 10b with BF3·Et2O/NaI/CH3CN affected simultaneous reduction of the sulfoxides to sulfide and removal of all protection groups yielding two distinctive 1-deoxy-4-thio-SRH analogs 12a and 12b, respectively.
Synthesis of [4-thio]-S-ribosylhomocysteine
The next target was [4- thioribose sulfoxides are known. [32] [33] [34] However, treatment of 10a with Ac2O at elevated temperature (100°C, 6 h) resulted in complex reaction mixture. In our efforts to synthesize thiohemiacetal 21, we then explored possibility of employing thioribosyl fluorides as precursors to O,S-acetals (Scheme 2). Thus, acetylation of 5 gave 13 and subsequent oxidation afforded sulfoxides 14 as a 4:1 mixture of diastereoisomers at sulfur. Interestingly, analogous treatment of sulfoxides 6 with Ac2O/DMAP failed to provide 14 probably due to H-bonding interaction between 5-hydroxy group and sulfoxide oxygen.
Treatment of sulfoxide 14 with DAST/SbCl3 combination 42 resulted in fluoro-Pummerer rearrangement to give α-fluoro thioether 15 (α/β,~1:20). Reaction of sulfide 13 with DAST/SbCl3 43 also produced thioribosyl fluorides 15. It is noteworthy that treatment of 14 or 13 with DAST alone provided 19 in much lower yields. Since α-fluoro thioethers are at the carbonyl oxidation level, these thioacetals are sensitive to acidic conditions. 42 We found that under slightly acidic conditions, such as even silica gel, a spontaneous hydrolysis of the α-fluoro thioethers 15 occurred to give thiohemiacetals 18. Since α-fluoro thioethers are relatively stable to basic conditions in parallel with acetals, treatment of 15 (β-anomer) with methanolic ammonia affected deacetylation providing 16 as a single β-anomer. The fluoride 16 was then mesylated at the primary hydroxyl to give reasonable stable 17. Rearrangement of mesylate 17 to the thiopyranose isomers of type 9b (in analogy to the formation of 9a upon attempted mesylation of 5 as depicted in Scheme 1) was also observed. We were fortunate to find that coupling of 17 with protected Hcy 24 
Pummerer rearrangement of [4-thio]-ribofuranose sulfoxides
To get insights of the unsuccessful Pummerer rearrangement of sulfoxide 10a (vide supra), we investigated properties of the model thiosugar sulfoxides 14 toward the Pummerer rearrangement. Thus, heating of the 14 with Ac2O (100°C/6 h) gave desired 1-O-acetyl-4-thioribose 22 (α/β = 1:4, 57%). Careful chromatographic purification yielded also the (acetoxy)vinyl ether byproduct 23 (20%) as single isomer (Scheme 3). Analogous treatment of the single sulfoxide 6 with Ac2O also produced a similar mixture of 22 (α/β = 1:5, 41%) and 23 (12%). 44 The enol acetate 23 is presumably formed by elimination of AcOH molecule from a regioisomeric Pummererrearranged 4-acetoxy intermediate. The chemical shifts and coupling constants for 23 are similar to those of the analogous vinyl derivatives in nucleoside series 45, 46 but NOESY 1 H NMR experiments were inconclusive to assign E or Z stereochemistry in the absence of both geometric isomers. Deacetylation of 22 with NH3/MeOH afforded thioribofuranose 24 (α/β = 1:9). Oxidation of 6 produced sulfone 25. However, attempted 5-O-mesylation of 25 led to the elimination of MsOH molecule providing exomethylene sulfone 26.
Conclusion
We have synthesized [4- Merck kieselgel 60 (230-400 mesh) was used for column chromatography. HPLC purifications were performed using XTerra preparative RP18 OBD column (5 μm 19 × 150 mm) with gradient program using CH3CN/H2O as a mobile phase. Reagent grade chemicals were used, and solvents were dried by reflux over and distillation from CaH2 (except for THF/potassium) under argon.
Experimental part
1-Deoxy-2,3-O-isopropylidene-S-oxo-4-thio-D-ribofuranose [6(SS)]
A solution of MCPBA (281 mg, 1.14 mmol,~70% reagent) in CH2Cl2 (4 mL) was added dropwise to a solution of 5 33 (216 mg, 1.14 mmol) in CH2Cl2 (2 mL) at −78°C, under Ar atmosphere. The resulting suspension was stirred for 30 min or until disappearance of 5 on TLC. The reaction mixture was treated with saturated NH3/MeOH (20 mL), and was allowed to warm to ambient temperature, and was evaporated. The residual white solid (~485 mg) was column chromatographed (20% MeOH/EtOAc) to give 6 32 (220 mg, 94%) as a colorless solidifying oil of a single diastereoisomer: 
1-Deoxy-2,3-O-isopropylidene-5-O-methanesulfonyl-S-oxo-4-thio-D-ribofuranose[7(SS)]
Et3N (0.464 mL, 337 mg, 3.34 mmol) and MsCl (0.129 mL, 191 mg, 1.67 mmol) were added dropwise to a stirred solution of 6 (160 mg, 0.78 mmol) in anhydrous CH2Cl2 (5 mL) at 0°C. After 4 h, the reaction mixture was quenched with saturated NaHCO3/H2O, and extracted with CH2Cl2. The combined organic layer was washed with brine, dried (Na2SO4), and evaporated. The crude product was column chromatographed (EtOAc → 5% MeOH/EtOAc) to give 7 (173 mg, 78%) as a colorless oil: 
4, 5-Didehydro-1,5-dideoxy-2,3-O-isopropylidene-S-oxo-4-thio-D-ribofuranose [8(SS)]
LDA (2.0 M//THF/heptane/PhEt, 0.13 mL, 0.26 mmol) was added to a stirred solution of 7 (35 mg, 0.12 mmol) in dry DMF (2.0 mL) under Ar atmosphere at ambient temperature. After 3 days, reaction was quenched by addition of saturated NaHCO3/H2O and was extracted with EtOAc. The combined organic layer was washed (brine), dried (Na2SO4) and evaporated to give crude product which was column chromatographed (5% MeOH/EtOAc) to give 8 (9.5 mg, 41%) as a colorless oil: 
4-Chloro-1,4-dideoxy-2,3-O-isopropylidene-5-thio-Dribopyranose and 4-chloro-1,4-dideoxy-2,3-O-isopropylidene-5-thio-L-lyxopyranose (9a)
Compound 5 (57.5 mg, 0.3 mmol) was treated with MsCl (0.11 mL, 156 mg, 1.37 mmol) in the presence of Et3N (0.38 mL, 276 mg, 2.73 mmol) as described in Section 4.2 (3 h). The crude product was column chromatographed (10% EtOAc/hexane) to give 9a (40.5 mg, 64%) as mixture of streoisomers (3:1). Major isomer had: 
S-
Step a. H2O (0.24 mL) and tris(2-carboxyethyl)phosphine hydrochloride (88 mg, 0.31 mmol) were added to a stirred solution of N,N′-di(tert-butoxycarbonyl)-L-homocystine di(tert-butyl) ester 11 (160 mg, 0.28 mmol) in anhydrous DMF (2.4 mL) at ambient temperature under Ar atmosphere. After 20 h, the reaction mixture [TLC (EtOAc/ hexane, 2:8) showed conversion of disulfide (Rf 0.55) into thiol (Rf 0.65)] was partitioned between EtOAc, and saturated NaHCO3/ H2O. The aqueous layer was extracted with EtOAc, and the combined organic layer was washed with brine, dried (Na2SO4), and concentrated to give N-tert-butoxycarbonyl-L-homocysteine tert-butyl ester (159 mg, 99%) as colorless oil of sufficient purity to be directly used in next step.
Step b. A freshly prepared (step a) homocysteine derivative (266 mg, 0.914 mmol) was dissolved in anhydrous DMF (2.0 mL), and was stirred under a vigorous stream of argon for 10 min at 0°C (ice-bath). Next, a solution of LDA (0.46 mL, 2.0 M/THF and heptane, 0.914 mmol) was added dropwise and after an additional 10 min thiosugar 7 (245 mg, 0.863 mmol) in anhydrous DMF (2.5 mL) was added via syringe. After 15 min, ice-bath was removed and the reaction mixture was stirred for 48 h at ambient temperature (TLC showed consumption of 7). Ice-cold saturated NH4Cl/ H2O was added and the resulting suspension was diluted with EtOAc. The organic layer was separated and the aqueous layer was extracted with EtOAc. The combined organic layer was washed with brine, dried (Na2SO4) and was evaporated to give 534 mg of yellow oil. The crude product was column chromatographed (80 → 90% EtOAc/hexane) to give a colorless oil (120 mg, 29%) of partially separable mixture of epimers 10a and 10b (45:55 
S-(1,5-Dideoxy-S-oxo-4-thio-D-ribofuranos-5-yl)-Lhomocysteine [11a(SS)]
Compound 10a (18 mg, 0.037 mmol) was dissolved in TFA/H2O (9:1, 1.5 mL), and the resulting mixture was stirred at ambient temperature for 2 h. Volatiles were evaporated and coevaporated with toluene to give 11a (10 mg, 94%) as a colorless oil: , 1H, H4), 3.72 (dd, J = 2.3, 15.1 Hz, 1H, H1′) 
S-(1,5-Dideoxy-S-oxo-4-thio-L-lyxofuranos-5-yl)-Lhomocysteine [11b(SS)]
Compound 10b (19 mg, 0.04 mmol) was treated with TFA/H2O as described in Section 4.6. Volatiles were evaporated and coevaporated twice with toluene to give 11b (10.9 mg, 97%) as colorless oil: 
S-(1,5-Dideoxy-4-thio-D-ribofuranos-5-yl)-L-homocysteine (12a)
NaI (45 mg, 0.3 mmol) followed by BF3·Et2O (29 μL, 32 mg, 0.224 mmol) were added to a stirred solution of 10a (12 mg, 0.025 mmol) in dried CH3CN (1.0 mL) under Ar atmosphere. The resulting mixture was stirred at ambient temperature for 2 h and then water (10 mL) was added. The volatiles were evaporated and the remaining aqueous solution (~8 mL) was washed with CHCl3. The water layer was evaporated to give crude 12a as a yellow solid. 
S-(1,5-Dideoxy-4-thio-L-lyxofuranos-5-yl)-L-homocysteine (12b)
Compound 10b (12 mg, 0.022 mmol) was treated with NaI (44 mg, 0.29 mmol) and BF3·Et2O (28 μL, 31 mg, 0.22 mmol), as described in Section 4.8, to give crude 12b as a yellow solid. HPLC (CH3CN/H2O, 5:95; tR = 17.1 min) purification gave 12b (2 mg, 30%) as colorless oil: 
5-O-Acetyl-1-deoxy-2,3-O-isopropylidene-4-thio-Dribofuranose (13)
DMAP (7 mg, 0.057 mmol) was added to a stirred solution of 5 33 (117 mg, 0.62 mmol) in Ac2O (6 mL) at ambient temperature. After 2.5 h, MeOH (15 mL) was added and resulting mixture was stirred for additional 1 h at 0°C. The volatiles were evaporated to give the crude 13 (136 mg, 95%), of sufficient purity to be directly used in next step: 
5-O-Acetyl-1-deoxy-2,3-O-isopropylidene-S-oxo-4-thio-Dribofuranose [14(R/S)S]
Compound 13 (136 mg, 0.59 mmol) was treated with MCPBA (138 mg, 0.56 mmol, 70%) as described in Section 4.1 (14 h, −78°C → RT). The reaction mixture was quenched with saturated NaHCO3/ H2O, and extracted with CH2Cl2. The combined organic layer was washed with brine, dried (Na2SO4), and evaporated. The crude product was column chromatographed (50% EtOAc/hexane) to give unchanged 13 (7 mg, 5%) followed by (EtOAc → 10% MeOH/EtOAc) 14 (133 mg, 91%) as a separable mixture (4:1) of two diastereoisomers. Major isomer had: (18) 4.12.1. Method A Deoxo-fluor (125 mg, 0.25 mL of 50% solution in THF, 0.57 mmol) was added to a stirred solution of sulfoxide 14 (15.5 mg, 0.11 mmol) in CH2Cl2 (0.5 mL) containing SbCl3 (30 mg, 0.13 mmol) under Ar atmosphere at ambient temperature. Reaction mixture was heated at 55°C for 3 h, and was quenched with saturated NaHCO3/H2O. The resulting mixture was extracted with CH2Cl2 and the combined organic layer was washed with brine, dried (Na2SO4), and evaporated. The crude product was column chromatographed (20 → 25% EtOAc/hexane) to give 15 (9 mg, 58%) as colorless oil of major β anomer. 38 (s, 3H, CH3), 1.56 (s, 3H, CH3) 34 (s, 3H, CH3), 1.52 (s, 3H,  CH3), 2.13 (s, 3H, Ac), 2.50 (br. s, OH), 3.63-3.68 (m, 1H, H4 
5-O-Acetyl-1-deoxy-1-fluoro-2,3-O-isopropylidene-4-thio-α/β-D-ribofuranose (15), and 5-O-acetyl-2,3-O-isopropylidene-4-thio-β-D-ribofuranose
Note
Stirring of 15 (5 mg 0.2 mmol) in THF (1 mL) in the presence of 0.1 N HCl (0.1 mL) at ambient temperature for 1 h gave 18 (4.7 mg, 95%) with data as reported above.
Method B
Sulfide 13 (27.5 mg, 0.12 mmol) was treated with deoxo-fluor (127 mg, 0.26 mL, 50% soln in THF, 0.59 mmol) and SbCl3 (30 mg, 0.13 mmol) as described above (method A, 4 h). The crude product was column chromatographed (20 → 25% EtOAc/hexane) to give major β anomer of 15 (14.5 mg, 49%) as colorless oil with data as reported above.
1-Deoxy-1-fluoro-2,3-O-isopropylidene-4-thio-β-Dribofuranose (16)
Compound 15 (β-anomer; 45 mg, 0.18 mmol) was dissolved in saturated methanolic ammonia solution (4 mL) and the resulting mixture was stirred for 15 h at ambient temperature. The volatiles were evaporated to give crude product 16 (37 mg, 99%) as a light yellow oil of sufficient purity to be used for next step. 
1-Deoxy-1-fluoro-2,3-O-isopropylidene-5-O-methanesulfonyl-4-thio-β-D-ribofuranose (17)
Compound 16 (37 mg, 0.18 mmol) was treated with MsCl (0.16 mL, 237 mg, 3.31 mmol) in the presence of Et3N (0.6 mL, 437 mg, 4.33 mmol) as described in Section 4.2 (18 h, 0°C → RT). The crude material (104 mg) was column chromatographed (20% EtOAc/hexane) to give rearranged byproduct 9b (2 mg, 5%). 
Method B
Compound 20 (6 mg, 0.012 mmol) was treated with aqueous TFA, as described in Section 4.6 (4 h), to give 21 (3 mg, 85%) as a colorless oil with spectral data identical to the sample of 21 from method A.
1,5-O-Diacetyl-2,3-O-isopropylidene-4-thio-α/β-Dribofuranose (22), and 5-O-acetyl-4,5-didehydro-1-deoxy-2,3-Oisopropylidene-4-thio-D-ribofuranose (23)
Method A
A solution of compound 14 (59 mg, 0.24 mmol) in Ac2O (5 mL) was heated at 100°C for 6 h. The reaction mixture was evaporated, coevaporated with toluene, and the residue was column chromatographed (25 → 30% EtOAc/hexane) to give 22 32 
Method B
Sulfoxide 6 (16 mg, 0.078 mmol) was heated with Ac2O (1.0 mL) as described above (method A, 110°C, 3.5 h). The crude reaction residue was column chromatographed (25 → 35% EtOAc/hexane) to give 22 (8.0 mg, 41%; α/β = 1:5) as separable mixture of anomers and less polar 23 (2.0 mg, 12%).
2,3-O-Isopropylidene-4-thio-α/β-D-ribofuranose (24)
Compound 22 (4 mg, 0.016 mmol; α/β = 1:5) was dissolved in saturated NH3/MeOH solution (3 mL) and the solution was stirred at ambient temperature for 15 h. The volatiles were evaporated to give 24 (3 mg, 91%, α/β = 1:9) as a colorless oil. Major β anomer had: 
2,3-O-Isopropylidene-S,S-dioxo-1-deoxy-4-thio-D-ribofuranose (25)
Oxidation of 6 (31 mg, 0.15 mmol) with MCPBA (69 mg, 0.30 mmol, 75%), as described in Section 4.1 (30 min at −78°C, followed by 2 h at RT; work up: NaHCO3/H2O//CH2Cl2; column: 80% EtOAc/hexane → 20% MeOH/EtOAc), gave 25 (27 mg, 80%) as white solid: 1 H NMR δ 1.38 (s, 3H, CH3), 1.57 (s, 3H, CH3), 3.33-3.40 (m,   2H, H1,4), 3.41-3.48 (m, 1H, H1′) 4.03 (dd, J = 4.6, 12.0 Hz, 1H, H5 
